{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T12:53:39Z","timestamp":1793364819424,"version":"4.5.0"},"reference-count":108,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"unspecified","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2023,4,6]]},"published-print":{"date-parts":[[2023,6]]},"abstract":"<jats:p>Interstitial lung disease (ILD) is a collective term representing a diverse group of pulmonary fibrotic and inflammatory conditions. Due to the diversity of ILD conditions, paucity of guidance and updates to diagnostic criteria over time, it has been challenging to precisely determine ILD incidence and prevalence. This systematic review provides a synthesis of published data at a global level and highlights gaps in the current knowledge base. Medline and Embase databases were searched systematically for studies reporting incidence and prevalence of various ILDs. Randomised controlled trials, case reports and conference abstracts were excluded. 80 studies were included, the most described subgroup was autoimmune-related ILD, and the most studied conditions were rheumatoid arthritis (RA)-associated ILD, systemic sclerosis associated (SSc) ILD and idiopathic pulmonary fibrosis (IPF). The prevalence of IPF was mostly established using healthcare datasets, whereas the prevalence of autoimmune ILD tended to be reported in smaller autoimmune cohorts. The prevalence of IPF ranged from 7 to 1650 per 100\u2009000 persons. Prevalence of SSc ILD and RA ILD ranged from 26.1% to 88.1% and 0.6% to 63.7%, respectively. Significant heterogeneity was observed in the reported incidence of various ILD subtypes. This review demonstrates the challenges in establishing trends over time across regions and highlights a need to standardise ILD diagnostic criteria.PROSPERO registration number: CRD42020203035.<\/jats:p>","DOI":"10.1136\/bmjresp-2022-001291","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T10:55:15Z","timestamp":1686567315000},"page":"e001291","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":123,"title":["Incidence and prevalence of interstitial lung diseases worldwide: a systematic literature review"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9784-416X","authenticated-orcid":false,"given":"Rikisha","family":"Shah Gupta","sequence":"first","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London, London, UK"},{"name":"Real-World Evidence, Gilead Sciences, Foster City, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ardita","family":"Koteci","sequence":"additional","affiliation":[{"name":"Imperial College London, London, UK"},{"name":"NIHR Imperial Biomedical Research Centre, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Morgan","sequence":"additional","affiliation":[{"name":"Imperial College London, London, UK"},{"name":"NIHR Imperial Biomedical Research Centre, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M","family":"George","sequence":"additional","affiliation":[{"name":"Royal Brompton and Harefield NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K","family":"Quint","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London, London, UK"},{"name":"Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,6,12]]},"reference":[{"key":"2025083112411440000_10.1.e001291.1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.165.2.ats01"},{"key":"2025083112411440000_10.1.e001291.2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01653-2015"},{"key":"2025083112411440000_10.1.e001291.3","first-page":"29","article-title":"Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis","volume":"7","author":"Olson","year":"2016","journal-title":"Patient Relat Outcome Meas"},{"key":"2025083112411440000_10.1.e001291.4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.semarthrit.2020.11.009","article-title":"Prevalence of interstitial lung disease in polymyositis and dermatomyositis: a meta-analysis from 2000 to 2020","volume":"51","author":"Sun","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"2025083112411440000_10.1.e001291.5","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3390\/diagnostics10040208","article-title":"Patients with interstitial lung disease secondary to autoimmune diseases: how to recognize them?","volume":"10","author":"Sambataro","year":"2020","journal-title":"Diagnostics"},{"key":"2025083112411440000_10.1.e001291.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2013.09.005"},{"key":"2025083112411440000_10.1.e001291.7","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.phrs.2017.04.010","article-title":"Interstitial lung disease induced by fluoxetine: systematic review of literature and analysis of vigiaccess, eudravigilance and a national pharmacovigilance database","volume":"120","author":"Deidda","year":"2017","journal-title":"Pharmacol Res"},{"key":"2025083112411440000_10.1.e001291.8","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.093690"},{"key":"2025083112411440000_10.1.e001291.9","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.21037\/jtd-19-4021","article-title":"The interstitial lung disease spectrum under a uniform diagnostic algorithm: a retrospective study of 1,945 individuals","volume":"12","author":"Guo","year":"2020","journal-title":"J Thorac Dis"},{"key":"2025083112411440000_10.1.e001291.10","unstructured":"Global Burden of Disease Collaborative Network . Global burden of disease study 2019 (GBD 2019) reference life table. Seattle, United States of America: Institute for Health Metrics and Evaluation (IHME), 2021."},{"key":"2025083112411440000_10.1.e001291.11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025083112411440000_10.1.e001291.12","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7100356","article-title":"Drug-induced interstitial lung disease: a systematic review","volume":"7","author":"Skeoch","year":"2018","journal-title":"J Clin Med"},{"key":"2025083112411440000_10.1.e001291.13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147072","article-title":"Epidemiology of idiopathic pulmonary fibrosis in northern Italy","volume":"11","author":"Harari","year":"2016","journal-title":"PLoS ONE"},{"key":"2025083112411440000_10.1.e001291.14","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-015-0165-1","article-title":"Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study","volume":"16","author":"Raimundo","year":"2016","journal-title":"BMC Pulm Med"},{"key":"2025083112411440000_10.1.e001291.15","doi-asserted-by":"crossref","first-page":"978","DOI":"10.5588\/ijtld.16.0003","article-title":"Incidence and prevalence of idiopathic interstitial pneumonia and idiopathic pulmonary fibrosis in Korea","volume":"20","author":"Lee","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025083112411440000_10.1.e001291.16","unstructured":"Zhang N , Kaul B , Lee JS , et al . Epidemiology of idiopathic pulmonary fibrosis among U.S. veterans, 2010-2019. Ann Am Thorac Soc 2021."},{"key":"2025083112411440000_10.1.e001291.17","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01504-2015"},{"key":"2025083112411440000_10.1.e001291.18","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-018-0693-1"},{"key":"2025083112411440000_10.1.e001291.19","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-015-0074-3","article-title":"Re-evaluation of diagnostic parameters is crucial for obtaining accurate data on idiopathic pulmonary fibrosis","volume":"15","author":"Kaunisto","year":"2015","journal-title":"BMC Pulm Med"},{"key":"2025083112411440000_10.1.e001291.20","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.201049"},{"key":"2025083112411440000_10.1.e001291.21","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/rheumatology\/keaa547","article-title":"Disease frequency, patient characteristics, comorbidity outcomes and immunosuppressive therapy in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: a US cohort study","volume":"60","author":"Li","year":"2021","journal-title":"Rheumatology"},{"key":"2025083112411440000_10.1.e001291.22","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.171315"},{"key":"2025083112411440000_10.1.e001291.23","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa836"},{"key":"2025083112411440000_10.1.e001291.24","doi-asserted-by":"crossref","first-page":"105124","DOI":"10.1016\/j.jbspin.2020.105124","article-title":"Sex differences in clinical characteristics and their influence on clinical outcomes in an observational cohort of patients with rheumatoid arthritis","volume":"88","author":"Shin","year":"2021","journal-title":"Jt Bone Spine"},{"key":"2025083112411440000_10.1.e001291.25","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3781-7"},{"key":"2025083112411440000_10.1.e001291.26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/art.41491","article-title":"Respiratory diseases as risk factors for seropositive and seronegative rheumatoid arthritis and in relation to smoking","volume":"73","author":"Kronzer","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"2025083112411440000_10.1.e001291.27","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028466","article-title":"Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERas and ERAN inception cohorts","volume":"9","author":"Kiely","year":"2019","journal-title":"BMJ Open"},{"key":"2025083112411440000_10.1.e001291.28","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s42358-021-00209-0","article-title":"Lung involvement prevalence in patients with early rheumatoid arthritis without known pulmonary disease: a multicentric cross sectional study","volume":"61","author":"Paulin","year":"2021","journal-title":"Adv Rheumatol"},{"key":"2025083112411440000_10.1.e001291.29","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-017-3561-5"},{"key":"2025083112411440000_10.1.e001291.30","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-020-00267-8"},{"key":"2025083112411440000_10.1.e001291.31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/08820139.2018.1425700","article-title":"Rheumatoid arthritis: a single-center Egyptian experience","volume":"47","author":"Sakr","year":"2018","journal-title":"Immunol Invest"},{"key":"2025083112411440000_10.1.e001291.32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejr.2020.08.004","article-title":"Rheumatoid arthritis patients with interstitial lung disease: clinical, radiological and laboratory characteristics","volume":"43","author":"Samy","year":"2021","journal-title":"Egypt Rheumatol"},{"key":"2025083112411440000_10.1.e001291.33","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/rheumatology\/kex072","article-title":"Effect of rituximab on the progression of rheumatoid arthritis\u2013related interstitial lung disease: 10 years\u2019 experience at a single centre","volume":"56","author":"Md Yusof","year":"2017","journal-title":"Rheumatology"},{"key":"2025083112411440000_10.1.e001291.34","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez177"},{"key":"2025083112411440000_10.1.e001291.35","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1007\/s10067-019-04760-6","article-title":"Assessment of interstitial lung disease among black rheumatoid arthritis patients","volume":"38","author":"McFarlane","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2025083112411440000_10.1.e001291.36","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/acr.24076","article-title":"Incidence, risk factors, and outcomes of cancer in systemic sclerosis","volume":"72","author":"Morrisroe","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025083112411440000_10.1.e001291.37","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/acr.24167","article-title":"Clinical features of systemic sclerosis-mixed connective tissue disease and systemic sclerosis overlap syndromes","volume":"73","author":"Fairley","year":"2021","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025083112411440000_10.1.e001291.38","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.semarthrit.2019.11.005","article-title":"Mortality and hospitalization outcomes of interstitial lung disease and pulmonary hypertension in the Singapore systemic sclerosis cohort","volume":"50","author":"Noviani","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2025083112411440000_10.1.e001291.39","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.semarthrit.2021.07.018","article-title":"Incidence, prevalence and long-term progression of goh algorithm rated interstitial lung disease in systemic sclerosis in two independent cohorts in Flanders: a retrospective cohort study","volume":"51","author":"Vandecasteele","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"2025083112411440000_10.1.e001291.40","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001728","article-title":"Registry of the Spanish network for systemic sclerosis: survival, prognostic factors, and causes of death","volume":"94","author":"Sime\u00f3n-Aznar","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2025083112411440000_10.1.e001291.41","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00296-017-3916-x","article-title":"Interstitial lung disease in systemic sclerosis: data from the Spanish scleroderma study group","volume":"38","author":"S\u00e1nchez-Cano","year":"2018","journal-title":"Rheumatol Int"},{"key":"2025083112411440000_10.1.e001291.42","doi-asserted-by":"crossref","unstructured":"Jaafar S , Lescoat A , Huang S , et al . Clinical characteristics, visceral involvement, and mortality in at-risk or early diffuse systemic sclerosis: a longitudinal analysis of an observational prospective multicenter US cohort. Arthritis Res Ther 2021;23. doi:10.1186\/s13075-021-02548-1","DOI":"10.1186\/s13075-021-02548-1"},{"key":"2025083112411440000_10.1.e001291.43","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000022443","article-title":"Relationship between calcifications and structural lesions on hand radiography and axial calcifications on CT-scan: a retrospective study in systemic sclerosis","volume":"99","author":"Bauer","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"2025083112411440000_10.1.e001291.44","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1007\/s10067-019-04659-2","article-title":"Unique clinical and autoantibody profile of a large Asian Indian cohort of scleroderma\u2014do South Asians have a more aggressive disease?","volume":"38","author":"Janardana","year":"2019","journal-title":"Clin Rheumatol"},{"key":"2025083112411440000_10.1.e001291.45","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1620\/tjem.239.297","article-title":"High prevalence of acute exacerbation of interstitial lung disease in Japanese patients with systemic sclerosis","volume":"239","author":"Tomiyama","year":"2016","journal-title":"Tohoku J Exp Med"},{"key":"2025083112411440000_10.1.e001291.46","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3109\/14397595.2015.1115455","article-title":"Incidence and predictors of interstitial lung disease (ILD) in Thai patients with early systemic sclerosis: inception cohort study","volume":"26","author":"Wangkaew","year":"2016","journal-title":"Mod Rheumatol"},{"key":"2025083112411440000_10.1.e001291.47","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000667","article-title":"Primary Sj\u00f6gren syndrome in Han Chinese: clinical and immunological characteristics of 483 patients","volume":"94","author":"Zhao","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2025083112411440000_10.1.e001291.48","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.autrev.2016.09.017","article-title":"Interstitial lung disease in primary Sj\u00f6gren\u2019s syndrome","volume":"16","author":"Roca","year":"2017","journal-title":"Autoimmun Rev"},{"key":"2025083112411440000_10.1.e001291.49","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/0961203320976932","article-title":"Clinical features and outcomes from the Singapore Sj\u00f6gren\u2019s syndrome study","volume":"30","author":"Kam","year":"2021","journal-title":"Lupus"},{"key":"2025083112411440000_10.1.e001291.50","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011003","article-title":"Prevalence, risk factors, and prognosis of interstitial lung disease in a large cohort of Chinese primary Sj\u00f6gren syndrome patients: a case-control study","volume":"97","author":"Gao","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"2025083112411440000_10.1.e001291.51","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000026777","article-title":"Characteristics and mortality in primary Sj\u00f6gren syndrome-related interstitial lung disease","volume":"100","author":"Gao","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"2025083112411440000_10.1.e001291.52","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.21037\/jtd.2018.03.120","article-title":"Risk factors for primary Sj\u00f6gren syndrome-associated interstitial lung disease","volume":"10","author":"Wang","year":"2018","journal-title":"J Thorac Dis"},{"key":"2025083112411440000_10.1.e001291.53","first-page":"94","article-title":"Prevalence and spectrum of symptomatic pulmonary involvement in primary Sj\u00f6gren\u2019s syndrome","volume":"36 Suppl 112","author":"Kampolis","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"2025083112411440000_10.1.e001291.54","doi-asserted-by":"crossref","DOI":"10.1007\/s10067-017-3635-4","article-title":"Erratum to: prevalence and characterization of non-sicca onset primary Sj\u00f6gren syndrome with interstitial lung involvement","volume":"36","author":"Manfredi","year":"2017","journal-title":"Clin Rheumatol"},{"key":"2025083112411440000_10.1.e001291.55","doi-asserted-by":"crossref","first-page":"405","DOI":"10.15537\/smj.2021.42.4.20200767","article-title":"Disease phenotype and diagnostic delay in Saudi patients with primary Sj\u00f6gren\u2019s syndrome","volume":"42","author":"Omair","year":"2021","journal-title":"SMJ"},{"key":"2025083112411440000_10.1.e001291.56","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2014.931457"},{"key":"2025083112411440000_10.1.e001291.57","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200247"},{"key":"2025083112411440000_10.1.e001291.58","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/JOM.0000000000002068","article-title":"Sex-related differences in the risk of silicosis among Chinese pottery workers: a cohort study","volume":"63","author":"Poinen-Rughooputh","year":"2021","journal-title":"J Occup Environ Med"},{"key":"2025083112411440000_10.1.e001291.59","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.3390\/ijerph18115625","article-title":"Association between crystalline silica dust exposure and silicosis development in artificial stone workers","volume":"18","author":"Requena-Mullor","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2025083112411440000_10.1.e001291.60","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ajim.23242","article-title":"Respiratory health and silicosis in artisanal mine workers in Southern Brazil","volume":"64","author":"Souza","year":"2021","journal-title":"Am J Ind Med"},{"key":"2025083112411440000_10.1.e001291.61","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ajim.22719","article-title":"Silicosis prevalence and risk factors in semi-precious stone mining in Brazil","volume":"60","author":"Souza","year":"2017","journal-title":"Am J Ind Med"},{"key":"2025083112411440000_10.1.e001291.62","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-015-2566-8","article-title":"Trends in silicosis prevalence and the healthy worker effect among gold miners in South Africa: a prevalence study with follow up of employment status","volume":"15","author":"Knight","year":"2015","journal-title":"BMC Public Health"},{"key":"2025083112411440000_10.1.e001291.63","doi-asserted-by":"publisher","DOI":"10.1136\/oemed-2020-106897"},{"key":"2025083112411440000_10.1.e001291.64","first-page":"598","article-title":"Prevalence of silicosis in stone carving workers being exposed to inorganic dust at sikhiu district nakhonratchasima Province, Thailand; preliminary results","volume":"100","author":"Silanun","year":"2017","journal-title":"J Med Assoc Thai"},{"key":"2025083112411440000_10.1.e001291.65","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4038\/cmj.v61i1.8252","article-title":"A study on silicosis among employees of a silica processing factory in the central province of Sri Lanka","volume":"61","author":"Siribaddana","year":"2016","journal-title":"Ceylon Med J"},{"key":"2025083112411440000_10.1.e001291.66","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.3346\/jkms.2015.30.12.1896","article-title":"CT findings in people who were environmentally exposed to asbestos in Korea","volume":"30","author":"Lee","year":"2015","journal-title":"J Korean Med Sci"},{"key":"2025083112411440000_10.1.e001291.67","doi-asserted-by":"crossref","DOI":"10.5334\/aogh.2575","article-title":"Prevalence of asbestos-related disease among workers in Sri Lanka","volume":"85","author":"Wickramatillake","year":"2019","journal-title":"Ann Glob Health"},{"key":"2025083112411440000_10.1.e001291.68","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1007\/s10067-021-05797-2","article-title":"Myositis-specific antibodies and clinical characteristics in patients with autoimmune inflammatory myopathies: reported by the Argentine registry of inflammatory myopathies of the Argentine society of rheumatology","volume":"40","author":"G\u00f3mez","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2025083112411440000_10.1.e001291.69","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3109\/14397595.2015.1054081","article-title":"Long-term follow-up of 124 patients with polymyositis and dermatomyositis: statistical analysis of prognostic factors","volume":"26","author":"Ishizuka","year":"2016","journal-title":"Mod Rheumatol"},{"key":"2025083112411440000_10.1.e001291.70","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1007\/s10072-020-04911-7","article-title":"The significance of myositis autoantibodies in idiopathic inflammatory myopathy concomitant with interstitial lung disease","volume":"42","author":"Huang","year":"2021","journal-title":"Neurol Sci"},{"key":"2025083112411440000_10.1.e001291.71","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1007\/s10067-020-05336-5","article-title":"Connective tissue disease -- associated interstitial lung disease: an underreported cause of interstitial lung disease in sub-Saharan Africa","volume":"40","author":"Olaosebikan","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2025083112411440000_10.1.e001291.72","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02419-2016","article-title":"Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of greater Paris","volume":"50","author":"Duchemann","year":"2017","journal-title":"Eur Respir J"},{"key":"2025083112411440000_10.1.e001291.73","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/rheumatology\/kex077","article-title":"Progression and mortality of interstitial lung disease in mixed connective tissue disease: a long-term observational nationwide cohort study","volume":"57","author":"Reiseter","year":"2018","journal-title":"Rheumatology"},{"key":"2025083112411440000_10.1.e001291.74","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/19338244.2020.1870911","article-title":"The relationship between respiratory health and hard metal dust exposure: a cross-sectional study","volume":"77","author":"\u015eim\u015fek","year":"2022","journal-title":"Arch Environ Occup Health"},{"key":"2025083112411440000_10.1.e001291.75","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/ijd.12633","article-title":"Epidemiology of sarcoidosis in afro-caribbean people: a 7-year retrospective study in Guadeloupe","volume":"54","author":"Coquart","year":"2015","journal-title":"Int J Dermatol"},{"key":"2025083112411440000_10.1.e001291.76","doi-asserted-by":"publisher","DOI":"10.1002\/ajim.22402"},{"key":"2025083112411440000_10.1.e001291.77","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.chest.2021.04.035","article-title":"Tobacco smoking and risk for pulmonary fibrosis: a prospective cohort study from the UK Biobank","volume":"160","author":"Bellou","year":"2021","journal-title":"Chest"},{"key":"2025083112411440000_10.1.e001291.78","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1032-6"},{"key":"2025083112411440000_10.1.e001291.79","doi-asserted-by":"crossref","first-page":"742","DOI":"10.5588\/ijtld.14.0650","article-title":"Incidence of idiopathic pulmonary fibrosis in Korea based on the 2011 ATS\/ERS\/JRS\/ALAT statement","volume":"19","author":"Gjonbrataj","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025083112411440000_10.1.e001291.80","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.3390\/ijerph120707444","article-title":"Comparison of the cumulative incidence rates of coal workers\u2019 pneumoconiosis between 1970 and 2013 among four state-owned colliery groups in China","volume":"12","author":"Cui","year":"2015","journal-title":"Int J Environ Res Public Health"},{"key":"2025083112411440000_10.1.e001291.81","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ajim.23245","article-title":"Incidence of mesothelioma and asbestosis by occupation in a diverse workforce","volume":"64","author":"DeBono","year":"2021","journal-title":"Am J Ind Med"},{"key":"2025083112411440000_10.1.e001291.82","first-page":"1","article-title":"Asbestos related diseases among workers of asbestos processing plants in relation to type of production and asbestos use","volume":"66","author":"Szeszenia-D\u0105browska","year":"2015","journal-title":"Med Pr"},{"key":"2025083112411440000_10.1.e001291.83","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-215041"},{"key":"2025083112411440000_10.1.e001291.84","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-015-0393-9","article-title":"Radiation-induced bronchiolitis obliterans organizing pneumonia (BOOP) syndrome in breast cancer patients is associated with age","volume":"10","author":"Murofushi","year":"2015","journal-title":"Radiat Oncol"},{"key":"2025083112411440000_10.1.e001291.85","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rry001"},{"key":"2025083112411440000_10.1.e001291.86","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201704-288OC"},{"key":"2025083112411440000_10.1.e001291.87","first-page":"24","article-title":"The incidence, comorbidity and mortality of sarcoidosis in Korea, 2008-2015: a nationwide population-based study","volume":"37","author":"Jeon","year":"2020","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2025083112411440000_10.1.e001291.88","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-021-01749-1","article-title":"Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the progress study)","volume":"22","author":"Nasser","year":"2021","journal-title":"Respir Res"},{"key":"2025083112411440000_10.1.e001291.89","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1007\/s12325-021-01786-8","article-title":"Prevalence and incidence of chronic fibrosing interstitial lung diseases with a progressive phenotype in the United States estimated in a large claims database analysis","volume":"38","author":"Olson","year":"2021","journal-title":"Adv Ther"},{"key":"2025083112411440000_10.1.e001291.90","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ajim.22944","article-title":"Silicosis prevalence and incidence among Medicare beneficiaries","volume":"62","author":"Casey","year":"2019","journal-title":"Am J Ind Med"},{"key":"2025083112411440000_10.1.e001291.91","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S2213-2600(20)30036-9","article-title":"Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial","volume":"8","author":"Wells","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2025083112411440000_10.1.e001291.92","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S2213-2600(20)30330-1","article-title":"Efficacy and safety of nintedanib in patients with systemic sclerosis-associated interstitial lung disease treated with mycophenolate: a subgroup analysis of the SENSCIS trial","volume":"9","author":"Highland","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2025083112411440000_10.1.e001291.93","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S2213-2600(20)30554-3","article-title":"Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (relief): a double-blind, randomised, placebo-controlled, phase 2B trial","volume":"9","author":"Behr","year":"2021","journal-title":"Lancet Respir Med"},{"key":"2025083112411440000_10.1.e001291.94","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2009-040GL"},{"key":"2025083112411440000_10.1.e001291.95","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201506-1063ST"},{"key":"2025083112411440000_10.1.e001291.96","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1255ST"},{"key":"2025083112411440000_10.1.e001291.97","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1513\/AnnalsATS.201610-764OC","article-title":"Code-based diagnostic algorithms for idiopathic pulmonary fibrosis. Case validation and improvement","volume":"14","author":"Ley","year":"2017","journal-title":"Annals ATS"},{"key":"2025083112411440000_10.1.e001291.98","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0b013e328363f48d"},{"key":"2025083112411440000_10.1.e001291.99","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201308-1483ST"},{"key":"2025083112411440000_10.1.e001291.100","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S2213-2600(20)30355-6","article-title":"Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities","volume":"8","author":"George","year":"2020","journal-title":"The Lancet Respiratory Medicine"},{"key":"2025083112411440000_10.1.e001291.101","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00085-2020"},{"key":"2025083112411440000_10.1.e001291.102","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/j.chest.2021.03.066","article-title":"Diagnosis and evaluation of hypersensitivity pneumonitis","volume":"160","author":"Fern\u00e1ndez P\u00e9rez","year":"2021","journal-title":"Chest"},{"key":"2025083112411440000_10.1.e001291.103","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.chest.2021.03.067","article-title":"Executive summary: diagnosis and evaluation of hypersensitivity pneumonitis","volume":"160","author":"Fern\u00e1ndez P\u00e9rez","year":"2021","journal-title":"Chest"},{"key":"2025083112411440000_10.1.e001291.104","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1013660"},{"key":"2025083112411440000_10.1.e001291.105","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801562"},{"key":"2025083112411440000_10.1.e001291.106","doi-asserted-by":"publisher","DOI":"10.1038\/nature15393"},{"key":"2025083112411440000_10.1.e001291.107","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2019.10.011"},{"key":"2025083112411440000_10.1.e001291.108","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202202-0399ST"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2022-001291","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T19:41:31Z","timestamp":1756669291000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2022-001291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":108,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,6,12]]},"published-print":{"date-parts":[[2023,6]]}},"alternative-id":["10.1136\/bmjresp-2022-001291"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2022-001291","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]}}}